Atrás
Rango del Día
$0.38
$0.40
Rango de 52 Semanas
$0.26
$0.40
Volumen
400
Promedio 50D / 200D
$0.38
/
$0.32
Cierre Anterior
$0.38
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 3.2 | 0.3 |
| P/B | 0.1 | 2.9 |
| ROE % | 3.5 | 3.7 |
| Net Margin % | 7.8 | 3.8 |
| Rev Growth 5Y % | 2.3 | 10.0 |
| D/E | 0.7 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$0.27
$0.25 – $0.29
|
7.8 B | 1 |
| FY2026 |
$0.19
$0.18 – $0.20
|
7 B | 1 |
Puntos Clave
Revenue grew 2.28% annually over 5 years — modest growth
Earnings declined -11.40% over the past year
ROE of 3.54% is below average
Negative free cash flow of -1.54B
P/E of 3.20 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.61%
Crecimiento
Revenue Growth (5Y)
2.28%
Revenue (1Y)-1.33%
Earnings (1Y)-11.40%
FCF Growth (3Y)N/A
Calidad
Return on Equity
3.54%
ROIC3.96%
Net Margin7.79%
Op. Margin21.30%
Seguridad
Debt / Equity
0.73
Current Ratio1.24
Interest Coverage2.30
Valoración
P/E Ratio
3.20
P/B Ratio0.11
EV/EBITDA5.34
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.33% | Revenue Growth (3Y) | 0.66% |
| Earnings Growth (1Y) | -11.40% | Earnings Growth (3Y) | -11.67% |
| Revenue Growth (5Y) | 2.28% | Earnings Growth (5Y) | -9.60% |
| Profitability | |||
| Revenue (TTM) | 6.06B | Net Income (TTM) | 471.89M |
| ROE | 3.54% | ROA | 1.59% |
| Gross Margin | 66.72% | Operating Margin | 21.30% |
| Net Margin | 7.79% | Free Cash Flow (TTM) | -1.54B |
| ROIC | 3.96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.73 | Current Ratio | 1.24 |
| Interest Coverage | 2.30 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 3.20 | P/B Ratio | 0.11 |
| P/S Ratio | 0.25 | PEG Ratio | -0.23 |
| EV/EBITDA | 5.34 | Dividend Yield | 0.00% |
| Market Cap | 1.51B | Enterprise Value | 6.89B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 6.06B | 6.14B | 5.98B | 5.20B | 5.54B |
| Net Income | 471.89M | 532.61M | 604.81M | -144.78M | 706.59M |
| EPS (Diluted) | 0.02 | 0.14 | 0.17 | -0.04 | 0.22 |
| Gross Profit | 4.04B | 4.20B | 4.14B | 3.40B | 3.99B |
| Operating Income | 1.29B | 1.03B | 1.21B | 386.99M | 1.42B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 29.61B | 25.49B | 24.25B | 22.58B | 20.63B |
| Total Liabilities | 13.86B | 11.96B | 13.21B | 13.47B | 12.53B |
| Shareholders' Equity | 14.15B | 12.53B | 10.18B | 8.49B | 7.89B |
| Total Debt | 10.32B | 8.42B | 9.10B | 9.49B | 9.98B |
| Cash & Equivalents | 4.94B | 3.24B | 2.32B | 2.44B | 3.87B |
| Current Assets | 13.31B | 10.70B | 10.79B | 10.40B | 9.97B |
| Current Liabilities | 10.77B | 8.14B | 9.49B | 7.33B | 7.23B |